537 related articles for article (PubMed ID: 17621733)
1. Ocular side effects of chloroquine in patients with rheumatoid arthritis, systemic lupus erythematosus and scleroderma.
Leecharoen S; Wangkaew S; Louthrenoo W
J Med Assoc Thai; 2007 Jan; 90(1):52-8. PubMed ID: 17621733
[TBL] [Abstract][Full Text] [Related]
2. Keratopathy with low dose chloroquine therapy.
Cullen AP; Chou BR
J Am Optom Assoc; 1986 May; 57(5):368-72. PubMed ID: 3711574
[TBL] [Abstract][Full Text] [Related]
3. Discontinuation of antimalarial drugs in systemic lupus erythematosus.
Wang C; Fortin PR; Li Y; Panaritis T; Gans M; Esdaile JM
J Rheumatol; 1999 Apr; 26(4):808-15. PubMed ID: 10229401
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with chloroquine-induced retinopathy in rheumatic diseases.
Araiza-Casillas R; Cárdenas F; Morales Y; Cardiel MH
Lupus; 2004; 13(2):119-24. PubMed ID: 14995005
[TBL] [Abstract][Full Text] [Related]
5. Comparison of phenytoin with auranofin and chloroquine in rheumatoid arthritis--a double blind study.
Rao UR; Naidu MU; Kumar TR; Shobha U; Askar MA; Ahmed N; Sarada P; Venubabu K; Shantaram V; Menon GN
J Rheumatol; 1995 Jul; 22(7):1235-40. PubMed ID: 7562751
[TBL] [Abstract][Full Text] [Related]
6. Double-blind, randomized, controlled clinical trial of clofazimine compared with chloroquine in patients with systemic lupus erythematosus.
Bezerra EL; Vilar MJ; da Trindade Neto PB; Sato EI
Arthritis Rheum; 2005 Oct; 52(10):3073-8. PubMed ID: 16200586
[TBL] [Abstract][Full Text] [Related]
7. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
Aylward JM
J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333
[TBL] [Abstract][Full Text] [Related]
8. Validation of the Thai version of a screening questionnaire for detection of systemic lupus erythematosus.
Kasitanon N; Louthrenoo W; Wangkaew S; Sukitawut W; Wichainun R
J Med Assoc Thai; 2006 Apr; 89(4):448-52. PubMed ID: 16696388
[TBL] [Abstract][Full Text] [Related]
9. [Eye toxicity of antimalarial agents].
Graña Gil J; Cabana Vázquez M; Vázquez González A; Sánchez Meizoso MO
An Med Interna; 2002 Apr; 19(4):189-91. PubMed ID: 12090061
[TBL] [Abstract][Full Text] [Related]
10. [Ocular changes and general condition in lupus erythematosus (SLE)--own observation].
Brydak-Godowska J
Klin Oczna; 2007; 109(1-3):11-4. PubMed ID: 17687904
[TBL] [Abstract][Full Text] [Related]
11. Current practices for monitoring ocular toxicity related to hydroxychloroquine (Plaquenil) therapy.
Mazzuca SA; Yung R; Brandt KD; Yee RD; Katz BP
J Rheumatol; 1994 Jan; 21(1):59-63. PubMed ID: 8151589
[TBL] [Abstract][Full Text] [Related]
12. Rituximab infusion-related adverse event rates are lower in patients with systemic lupus erythematosus than in those with rheumatoid arthritis.
Conti F; Ceccarelli F; Perricone C; Alessandri C; Conti V; Massaro L; Truglia S; Spinelli FR; Spadaro A; Valesini G
Rheumatology (Oxford); 2011 Jun; 50(6):1148-52. PubMed ID: 21278072
[TBL] [Abstract][Full Text] [Related]
13. Skin and ophthalmic complications of chloroquine and hydroxychloroquine in patients with rheumatoid arthritis and systemic lupus erythematous.
Zamani B; Hasan-Abad AM; Rafizadeh SM; Akbari H; Motedayyen H
J Immunoassay Immunochem; 2024 May; 45(3):178-188. PubMed ID: 38722204
[TBL] [Abstract][Full Text] [Related]
14. [The ERG contribution in early diagnosis of chloroquine and hydroxychloroquine maculopathy].
Karkanová M; Matusková V; Vlková E; Dosková H; Uhmannová R
Cesk Slov Oftalmol; 2010 Apr; 66(2):62-6. PubMed ID: 20925239
[TBL] [Abstract][Full Text] [Related]
15. Antimalarial drug induced decrease in creatinine clearance.
Landewé RB; Vergouwen MS; Goeei The SG; Van Rijthoven AW; Breedveld FC; Dijkmans BA
J Rheumatol; 1995 Jan; 22(1):34-7. PubMed ID: 7699677
[TBL] [Abstract][Full Text] [Related]
16. [Chloroquine cardiotoxicity in long-term lupus therapy in two patients].
Saussine A; Loriot MA; Picard C; Lecerf V; Landry J; Scheer I; Voicu S; Leenhardt A; Ducrocq G; Maubec E; Crickx B
Ann Dermatol Venereol; 2009; 136(6-7):530-5. PubMed ID: 19560616
[TBL] [Abstract][Full Text] [Related]
17. Retinopathy due to antimalarial drugs in patients with connective tissue diseases: are they so innocent? A single center retrospective study.
Kobak S; Deveci H
Int J Rheum Dis; 2010 Aug; 13(3):e11-5. PubMed ID: 20704603
[TBL] [Abstract][Full Text] [Related]
18. [2 cases of neuromyopathy induced by antimalarials (retrospective diagnosis)].
Panahi F; Braun S; Guiraudon C; Delbarre F
Bull Mem Soc Med Hop Paris; 1968 Feb 9-16; 119(3):223-39. PubMed ID: 5703989
[No Abstract] [Full Text] [Related]
19. Ocular damage in chloroquine therapy.
Nylander U
Acta Ophthalmol (Copenh); 1967; ():Suppl 92:1-71. PubMed ID: 4866642
[No Abstract] [Full Text] [Related]
20. Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus.
Wolfe F; Marmor MF
Arthritis Care Res (Hoboken); 2010 Jun; 62(6):775-84. PubMed ID: 20535788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
